HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin Schecklmann Selected Research

Tinnitus

11/2022Random Forest Classification to Predict Response to High-Definition Transcranial Direct Current Stimulation for Tinnitus Relief: A Preliminary Feasibility Study.
1/2022Personalization of Repetitive Transcranial Magnetic Stimulation for the Treatment of Chronic Subjective Tinnitus.
12/2021Unification of Treatments and Interventions for Tinnitus Patients (UNITI): a study protocol for a multi-center randomized clinical trial.
6/2021Heading for Personalized rTMS in Tinnitus: Reliability of Individualized Stimulation Protocols in Behavioral and Electrophysiological Responses.
1/2021Conventional versus notch filter amplification for the treatment of tinnitus in adults with mild-to-moderate hearing loss.
1/2021Prediction of response to repetitive transcranial magnetic stimulation in phantom sounds based on individual brain anatomy.
1/2021Towards a unification of treatments and interventions for tinnitus patients: The EU research and innovation action UNITI.
1/2021The more the merrier? Preliminary results regarding treatment duration and stimulation frequency of multisite repetitive transcranial magnetic stimulation in chronic tinnitus.
10/2020Bimodal neuromodulation combining sound and tongue stimulation reduces tinnitus symptoms in a large randomized clinical study.
1/2020Short-Term Tinnitus Suppression With Electric-Field Guided rTMS for Individualizing rTMS Treatment: A Technical Feasibility Report.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martin Schecklmann Research Topics

Disease

40Tinnitus
11/2022 - 01/2011
6Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
09/2014 - 12/2008
5Schizophrenia (Dementia Praecox)
09/2018 - 08/2011
3Epilepsy (Aura)
01/2017 - 01/2012
3Autism Spectrum Disorder
09/2014 - 09/2011
2Depressive Disorder (Melancholia)
02/2022 - 01/2019
2Psychotic Disorders (Schizoaffective Disorder)
10/2020 - 06/2014
2Mood Disorders (Mood Disorder)
09/2014 - 01/2012
2Mental Disorders (Mental Disorder)
01/2013 - 11/2012
1Bipolar Disorder (Manic Depressive Psychosis)
02/2022
1Hearing Loss (Hearing Impairment)
01/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2017
1Stroke (Strokes)
01/2017
1Multiple Sclerosis
01/2017
1Neuralgia (Stump Neuralgia)
01/2017
1Fibromyalgia (Fibrositis)
01/2017
1Pain (Aches)
01/2017
1Parkinson Disease (Parkinson's Disease)
01/2017
1Consciousness Disorders
01/2017
1Aphasia (Dysphasia)
01/2017
1Movement Disorders (Movement Disorder)
01/2017
1Dementia (Dementias)
07/2012
1Hypothermia
07/2012
1Sleep Deprivation
04/2012

Drug/Important Bio-Agent (IBA)

5salicylhydroxamic acid (SHAM)IBA
01/2022 - 01/2016
4Dopamine (Intropin)FDA LinkGeneric
11/2011 - 12/2008
3Biomarkers (Surrogate Marker)IBA
01/2021 - 09/2011
3Pharmaceutical PreparationsIBA
01/2017 - 06/2014
3Antipsychotic Agents (Antipsychotics)IBA
06/2014 - 07/2012
2Therapeutic UsesIBA
01/2017 - 01/2012
2Messenger RNA (mRNA)IBA
09/2014 - 09/2011
2Quetiapine Fumarate (Seroquel)FDA Link
06/2014 - 06/2014
2Methylphenidate (Ritalin)FDA LinkGeneric
11/2011 - 12/2008
1E 10 (E-10)IBA
01/2019
1O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA
01/2019
1PlacebosIBA
01/2016
1Nerve Growth Factors (Neurotrophins)IBA
09/2014
1Proteins (Proteins, Gene)FDA Link
09/2014
1Oxytocin (Pitocin)FDA LinkGeneric
09/2014
1Brain-Derived Neurotrophic Factor (BDNF)IBA
09/2014
1N 30IBA
06/2014
1Indicators and Reagents (Reagents)IBA
01/2014
1Biological ProductsIBA
11/2012
1Olanzapine (Zyprexa)FDA Link
07/2012
1BenperidolIBA
07/2012
1Antidepressive Agents (Antidepressants)IBA
04/2012
1cyclobenzaprineFDA LinkGeneric
01/2012
1Nitric Oxide Synthase (NO Synthase)IBA
08/2011
1Glutamic Acid (Glutamate)FDA Link
08/2011
1Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
08/2011
1Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2011

Therapy/Procedure

28Transcranial Magnetic Stimulation
02/2022 - 01/2011
6Therapeutics
12/2021 - 07/2012
4Transcranial Direct Current Stimulation
11/2022 - 02/2012
4Aftercare (After-Treatment)
10/2020 - 01/2016
2Hearing Aids (Hearing Aid)
12/2021 - 01/2021
2Duration of Therapy
01/2021 - 01/2019
2Electrodes (Electrode)
01/2015 - 02/2012
2Vagus Nerve Stimulation
09/2014 - 01/2012
1Combined Modality Therapy
01/2018
1Relaxation Therapy (Relaxation Technique)
10/2016
1Drug Therapy (Chemotherapy)
01/2012